Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Advanced Medicine

Manufacture Advanced Medicine

Advanced Medicine: Replicating the mAb Success Story

| Stephanie Sutton

How can manufacturing be improved for viral vectors?

Business & Regulation Business Practice

One Vision, One Culture, One Team

| Rich Whitworth

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.

Manufacture Advanced Medicine

Regulate with the Times

| Claudia Zylberberg

Claudia Zylberberg explains the importance of ancillary material quality for advancing cell and gene therapies.

Manufacture Advanced Medicine

Advanced Medicine In Brief

| James Strachan

The world’s largest cell and gene CDMO, an exciting new TCR, and the global CAR T picture… We examine what’s going on in advanced medicine.

Manufacture Advanced Medicine

Cost of a Cure

| James Strachan

Gene therapies (including CAR T) could add $45 billion to US healthcare costs over the next five years, a CVS health report finds.

Manufacture Advanced Medicine

Manufacturing by Design

| Frederic Revah

Let’s reduce gene therapy manufacturing costs by optimizing cell lines, improving transfectants, and optimizing downstream purification.

Manufacture Advanced Medicine

The Pharmaceutical Nomad

| James Strachan

Sitting Down With... Miguel Forte, Chief Executive Officer at Bone Therapeutics, Belgium, to discuss advanced medicine.

Manufacture Advanced Medicine

Hands Off the Goods

| Chris Procyshyn

Aseptic filling is the final manufacturing step but it shouldn’t be an afterthought.

Manufacture Advanced Medicine

Point of Care, Point of Commercialization

| James Strachan

UC Davis joins Orgenesis’ point-of-care network to develop and commercialize cell and gene therapies in house.

Manufacture Advanced Medicine

Driving CAR T Cell Therapy

| James Strachan

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.


Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

Measurement of the concentration of Adeno-Associated Virus

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register